NCT05658406View on ClinicalTrials.gov

Supplemental Perioperative Intravenous Crystalloids for Postoperative Nausea and Vomiting in Children Undergoing Oncological Surgery

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 10, 2022

Primary Completion Date

July 5, 2022

Study Completion Date

September 27, 2022

Conditions
Nausea and Vomiting, Postoperative
Interventions
DRUG

Ringer's Lactate

infusion of 15 mL/kg/hour Ringer's lactate intraoperative

DRUG

Ringer's Lactate

infusion of 10 mL/kg/hour Ringer's lactate intraoperative .

DRUG

Ringer's Lactate

infusion of 6 mL/kg/hour Ringer's lactate intraoperative .

DRUG

normal Saline

standard fluid management: 4 ml for 1st 10 kg, 2 ml for the next 10 kg , 1 ml rest of body weight

Trial Locations (1)

21615

Alexandria University Faculty of Medicin, Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER

NCT05658406 - Supplemental Perioperative Intravenous Crystalloids for Postoperative Nausea and Vomiting in Children Undergoing Oncological Surgery | Biotech Hunter | Biotech Hunter